Search clinical trials for: Varenicline solution

Total 19646 results

Oyster Point Pharma, Inc.

Completed

Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline

Healthy Subjects

United States
Pfizer

Completed

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin

Smoking Cessation

United States
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
Stephenson Eye Associates

Recruiting

A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray (TSUNAMI)

Dry Eye Disease

United States
NYU Langone Health
Pfizer

Withdrawn

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (VarenSmoke)

Nicotine Dependence

United States
American University of Beirut Medical Center
Pfizer

Completed

Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation

Nicotine Dependence

Lebanon
Cornea and Laser Eye Institute

Recruiting

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

Keratoconus | Corneal Ectasia

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. (ECSMOKE)

Smoking Cessation | Smoking, Cigarette | Electronic Cigarette

France
University of Pennsylvania
Oyster Point Pharma, Inc.

Completed

Nasal Spray Study in Sjogren's Dry Eye Disease

Dry Eye | Sjogren's Syndrome

United States
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Arizona State University
National Institute on Drug Abuse (NIDA); Pfizer; University of Nevada, Reno; Los...

Completed

Varenicline OTC Trial on Efficacy and Safety (VOTC)

Smoking Cessation | Withdrawal Symptoms | Tobacco Dependence

United States
Pfizer

Withdrawn

A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation

Smoking Cessation
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Methamphetamine Addiction | Crystal Meth Addiction | Amphetamine Addiction

United States
Butler Hospital
Brown University

Completed

Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers

Depressive Disorder | Smoking

United States
Korea University Anam Hospital

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

Healthy

Korea, Republic of
Medical University of South Carolina

Completed

Hollings Cancer Center Varenicline Sampling Study

Smoking | Smoking Cessation | Smoking, Tobacco | Smoking, Cigarette

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Enrolling by invitation

Cessation Screening Project

Nicotine Dependence

United States
Pfizer

Completed

Smoking Cessation Study In Healthy Adolescent Smokers

Smoking Cessation

United States, Korea, Republic of, Taiwan, Canada, Georgia, Russian Federation
Duke University
National Institute on Drug Abuse (NIDA); Pfizer

Completed

Adaptive Pharmacotherapy for Smoking Cessation

Nicotine Dependence

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...

Active, not recruiting

A Trial of Directly Observed and Long-term Varenicline

Tobacco Use Disorder | Opioid-use Disorder

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery (DRIFTER)

Type 2 Diabetes | Bariatric Surgery

France
University of Minnesota

Completed

Improving Varenicline Adherence and Outcomes in Homeless Smokers

Tobacco Use Cessation

United States
Massachusetts General Hospital

Terminated

Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)

Smoking Cessation | Attention Deficit/Hyperactivity Disorder
Pfizer

Completed

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation

Smoking Cessation

Korea, Republic of, Taiwan
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
Medical University of South Carolina

Completed

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers (GRAND)

Nicotine Dependence

United States
University of South Florida
Pfizer; National Ataxia Foundation; Bob Allison Ataxia Research Center (BAARC)

Completed

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Spinocerebellar Ataxia Type 3

United States
Butler Hospital
Brown University

Withdrawn

Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients

Depressive Disorder | Smoking

United States
Roswell Park Cancer Institute
Pfizer

Completed

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Smoking Cessation

United States
Memorial Sloan Kettering Cancer Center
Pfizer

Terminated

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Breast Cancer | Tobacco Dependence

United States
Pfizer

Completed

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking (ASIA CHOICES)

Smoking Cessation

Korea, Republic of, China, Philippines, India
Pfizer

Completed

12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation

Smoking Cessation

Japan
Pfizer

Completed

An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation

Smoking Cessation

United States, United Kingdom, Belgium, France, Netherlands
Pfizer

Completed

A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline

Smoking Cessation

United States, Australia
Nathan Kline Institute for Psychiatric Research

Completed

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Schizophrenia | Cigarette Smoking

United States, China, Israel
Johns Hopkins University
Pfizer

Completed

Relapse Prevention With Varenicline (0815)

Substance-Related Disorders | Smoking Cessation | Recurrence

United States
Pfizer

Completed

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Smoking Cessation

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Varenicline for Smoking Cessation in Heavy Drinking Smokers

Smoking | Nicotine Dependence | Heavy Drinking
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Terminated

A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation

Nicotine Addiction

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement

Tobacco Dependence

United States
Pfizer

Completed

A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation

Smoking Cessation

United States, Canada, Norway, Sweden, United Kingdom, Czech Republic, Denmark
University of Wisconsin, Madison
Pfizer

Completed

Long-term Varenicline Treatment for Smoking Cessation

Smoking

United States
University Hospital, Gentofte, Copenhagen
Pfizer

Unknown

Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users

Tobacco Dependence

Denmark
Pfizer

Completed

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Smoking Cessation

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
Pfizer

Withdrawn

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Schizophrenia
Pfizer

Completed

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Smoking Cessation

United States
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS)

Recruiting

Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study

Smoking Cessation | Medication Adherence

Canada
University of South Florida
Pfizer; Friedreich's Ataxia Research Alliance

Terminated

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

Friedreich's Ataxia

United States

Search clinical trials for: Varenicline solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations